Case study: Primary open-angle glaucoma

Lance, 61-year-old man, is noted to have increased intraocular pressure on a routine eye examination. The visual acuity is normal in both eyes. The dilated eye examination reveals no evidence of optic nerve damage. Visual field testing shows mild loss of peripheral vision. He is diagnosed with primary open-angle glaucoma and is started on pilocarpine ophthalmic drops. What is the action of pilocarpine on the muscles of the iris and cilia? Is pilocarpine the appropriate first-line drug for the treatment of primary open-angle glaucoma?

Each case study presentation will include:
1.    Pathophysiology of the disease or physiology of the organism that the drug(s) are addressing.
2.    What drugs are commonly used to treat which pathophysiological states?
3.    What is/are the drug(s) of choice and why?
4.    What organ systems/tissues are being targeted?
5.    What are the reasons second and third-line drugs may be used?

Please advise the writer to refrain from using the word “I”. Please read the required format Per the instructor “As this is a pharmacology course, please try to keep, as much as possible, your posts related to pharmacology, prescribing practices, pharmacodynamics, and pharmacokinetics, especially when it relates to evidence-based treatments and national guidelines. When writing discussion posts about pharmacology, prescribing practices, pharmacodynamics, pharmacokinetics, evidence-based treatments, and national guidelines, it is often unnecessary to use the word "I." The focus of the discussion is pharmacology, prescribing practices, pharmacodynamics, pharmacokinetics, evidence-based treatments, and national guidelines--something generalizable to the public and not necessarily personal experiences. Since you are all going to become nurse practitioners, I recommend you all start using provider-neutral language like "provider," "clinician," or "practitioner"